Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13806 |
OR-1855
|
Others | Others |
OR-1855 is an active Levosimendan metabolite, has effect on human myometrial contractility. | |||
T2530 |
Levosimendan
OR1259,OR1855,左西孟旦 |
Potassium Channel; PDE; Carbonic Anhydrase; Autophagy | Autophagy; Membrane transporter/Ion channel; Metabolism |
Levosimendan (OR1259) 是一种钙增敏剂,通过以钙依赖性方式与心肌肌钙蛋白 C 结合,增加肌细胞对钙的敏感性来发挥其作用,可治疗急性失代偿性充血性心力衰竭。 |